Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO2021067857 - DISPOSITIF ET MÉTHODE D'AMÉLIORATION DE RÉTENTION D'UNE THÉRAPIE DANS LA VESSIE

Numéro de publication WO/2021/067857
Date de publication 08.04.2021
N° de la demande internationale PCT/US2020/054131
Date du dépôt international 02.10.2020
CIB
A61M 25/00 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
MDISPOSITIFS POUR INTRODUIRE DES AGENTS DANS LE CORPS OU LES DÉPOSER SUR CELUI-CI; DISPOSITIFS POUR FAIRE CIRCULER DES AGENTS DANS LE CORPS OU POUR LES EN RETIRER; DISPOSITIFS POUR PROVOQUER LE SOMMEIL OU LA LÉTHARGIE OU POUR Y METTRE FIN
25Cathéters; Sondes creuses
CPC
A61K 9/0034
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
A61K 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
A61K 9/145
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
145with organic compounds
A61K 9/146
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
146with organic macromolecular compounds
A61K 9/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
A61K 9/1629
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1605Excipients; Inactive ingredients
1629Organic macromolecular compounds
Déposants
  • WATERSHED MEDICAL, INC. [US]/[US]
Inventeurs
  • KINSELLA JR., Christopher Ralph
  • NOLAN, Clay
  • BARTLETT, Rush
Mandataires
  • BAGADE, Sanjay S.
  • GALLAGHER, Laura L.
  • HAN, Johney U.
  • LEVINE, David A.
  • MCADAMS, Grant R.
  • PAEZ, Lucas M.
  • XU, Daniel X.
Données relatives à la priorité
62/909,23702.10.2019US
62/910,10403.10.2019US
63/029,29622.05.2020US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) DEVICE AND METHOD FOR IMPROVING RETENTION OF A THERAPY IN THE BLADDER
(FR) DISPOSITIF ET MÉTHODE D'AMÉLIORATION DE RÉTENTION D'UNE THÉRAPIE DANS LA VESSIE
Abrégé
(EN)
Devices that are placed within fluid filled organs, such as the bladder, which reduce the risk of bacterial infections using a combination of active agents and mechanical disruption of bacteria.
(FR)
L'invention porte sur des dispositifs qui sont placés dans des organes remplis de fluide, tels que la vessie, qui réduisent le risque d'infections bactériennes à l'aide d'une association d'agents actifs et de perturbation mécanique de bactéries.
Dernières données bibliographiques dont dispose le Bureau international